This chemical is primarily used in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) that target neurological and psychiatric disorders. It serves as a key intermediate in the production of compounds that interact with serotonin and dopamine receptors, making it valuable for creating drugs aimed at treating conditions like depression, anxiety, and Parkinson's disease. Additionally, its fluorinated aromatic structure enhances the metabolic stability and bioavailability of the resulting compounds, improving their efficacy in therapeutic applications. It is also utilized in research settings for the development of novel bioactive molecules and as a building block in organic chemistry for the creation of complex structures.